UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

________________
 
Form 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2006March 31, 2005

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition period from ________ to ________ .

Commission file number: 0-20671
 
Renaissance Capital Growth & Income Fund III, Inc.
(Exact name of registrant as specified in its charter)
 
TX
(State75-2533518
 (State or other jurisdiction
of incorporation or organization)
75-2533518
(I.R.S. (I.R.S. Employer
Identification No.)
8080 N. Central Expressway, Suite 210, LB-59, Dallas, TX
75206
(Address
 (Address of principal executive offices)
75206
(Zip (Zip Code)
 
Registrant’s telephone number, including area code: 214-891-8294
 
None
(Former name, former address and former fiscal year
if changed since last report)
___________________


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes o No þ√     .

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule12b-2 of the Exchange Act. (Check one):

Large accelerated filer £Accelerated filer £Non-accelerated filer xS

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No þ√     .


As of October 31,December 1, 2006, the issuer had 4,463,967 shares of common stock outstanding.





RENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC.

INDEX

  
Page Number
NumberPART I. FINANCIAL INFORMATION
 
Item 1.
Financial Statements (Unaudited)
3
PART I. FINANCIAL INFORMATION
   
 
Item 1. Financial Statements (Unaudited)
3
Statements of Assets and Liabilities as of September 30, 2006March 31, 2005 and December 31, 200520043
   
 
Schedules of Investments as of September 30, 2006March 31, 2005 and December 31, 200520044
   
 
Statements of Operations for the three months ended March 31, 2005 and nine months ended September 30, 2006 and 200520041516
   
 
Statements of ChangeChanges in Net Assets for the ninethree months ended September 30, 2006March 31, 2005 and 2005200417
   
 
Statements of Cash Flows for the ninethree months ended September 30, 2006March 31, 2005 and 2005200418
   
 
Notes to Financial Statements19
   
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
2426
   
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
2829
   
Item 4.
Controls and Procedures
29
  28 
  
   
PART II. OTHER INFORMATION
 
   
Item 1.Legal Proceedings
Legal Proceedings
2930
   
Item 1A.Risk Factors
Risk Factors
2930
   
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
3233
   
Item 3.
Defaults Upon Senior Securities
3233
   
Item 4.
Submission of Matters to a Vote of Security Holders
3233
   
Item 5.Other Information
Other Information
3233
   
Item 6.Exhibits
Exhibits
3233




PART I - FINANCIAL INFORMATION

ITEMItem 1. FINANCIAL STATEMENTSFinancial Statements

Renaissance Capital Growth & Income Fund III, Inc.
Statements of Assets and Liabilities
(Unaudited)

  September 30, 2006 December 31, 2005 
      
ASSETS     
Cash and cash equivalents $16,441,071 $8,396,052 
Investments at fair value, cost of $37,280,584       
and $35,433,480 at September 30, 2006 and       
December 31, 2005, respectively  38,315,651  54,002,499 
Interest and dividends receivable  136,423  48,226 
Prepaid and other assets  10,921  101,598 
        
  $54,904,066 $62,548,375 
        
LIABILITIES AND NET ASSETS       
        
Liabilities:       
Due to broker $ $2,075,975 
Accounts payable  119,313  86,782 
Accounts payable - affiliate  673,763  2,050,989 
Accounts payable - dividends    4,145,686 
        
   793,076  8,359,432 
        
Commitments and contingencies       
        
Net assets:       
Common stock, $1 par value; authorized       
20,000,000 shares; 4,673,867 issued;       
4,463,967 shares outstanding  4,673,867  4,673,867 
Additional paid-in-capital  31,790,153  32,681,024 
Treasury stock at cost, 209,900  (1,734,967) (1,734,967)
Distributable earnings  18,346,870   
Net unrealized appreciation of investments  1,035,067  18,569,019 
        
Net assets, equivalent to $12.12 and $12.14       
per share at September 30, 2006 and       
December 31, 2005, respectively  54,110,990  54,188,943 
        
  $54,904,066 $62,548,375 
ASSETS
  
March 31,
2005
 
December 31,
2004
 
      
Cash and cash equivalents $24,962,028 $37,278,871 
Investments at fair value, cost of $36,062,057 and $38,096,399
at March 31, 2005 and December 31, 2004, respectively
  56,908,970  76,203,302 
Accounts receivable - settlement with affiliate  3,775,872  3,775,872 
Interest and dividends receivable  106,169  95,689 
Prepaid and other assets  92,796  33,375 
  $85,845,835 $117,387,109 
       
LIABILITIES AND NET ASSETS
 
       
Liabilities:      
Due to broker $19,992,670 $27,001,414 
Accounts payable  96,896  51,477 
Accounts payable - affiliate  3,562,507  3,697,461 
Accounts payable - dividends    12,054,258 
   23,652,073  42,804,610 
        
Commitments and contingencies      
       
Net assets:      
Common stock, $1 par value; authorized 20,000,000 shares; 4,673,867
and 4,561,618 issued; 4,463,967 and 4,351,718 shares outstanding
  4,673,867  4,561,618 
Additional paid-in-capital  34,754,220  33,641,903 
Treasury stock at cost, 209,900 shares  (1,734,967) (1,734,967)
Distributable earnings  3,653,729  7,042 
Net unrealized appreciation of investments  20,846,913  38,106,903 
       
Net assets, equivalent to $13.93 and $17.14 per share at March 31, 2005
and December 31, 2004, respectively
  62,193,762  74,582,499 
  $85,845,835 $117,387,109 
 
See accompanying notes
 
3


Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments
(unaudited)
  September 30, 2006 
  Interest Rate
 
Due Date
 
Cost
 
Fair Value
 
% of Net Investments 
Eligible Portfolio Investments -           
Convertible Debentures and           
Promissory Notes           
            
CaminoSoft Corp. -           
Promissory note (4)  7.00% 01/19/08 $250,000 $250,000  0.65%
                 
iLinc Communications, Inc. -                
Convertible promissory note (2)  12.00  03/29/12  500,000  500,000  1.30 
                 
Integrated Security Systems, Inc. -                
Promissory note (4)  8.00  09/30/07  525,000  525,000  1.37 
Promissory note (4)  7.00  09/30/07  200,000  200,000  0.52 
Promissory note (4)  8.00  09/30/07  175,000  175,000  0.46 
Convertible promissory note (2)  8.00  12/14/08  500,000  500,000  1.31 
                 
Simtek Corporation -                
Convertible debenture (2)  7.50  06/28/09  900,000  2,127,273  5.55 
                 
        $3,050,000 $4,277,273  11.16%
See accompanying notes
4


Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments
(unaudited)

  September 30, 2006 
  Interest Rate
 
Due Date
 
Cost Fair Value % of Net Investments 
Other Portfolio Investments -           
Convertible Debentures and           
Promissory Notes           
            
Integrated Security Systems, Inc. -           
Convertible debenture (4)  6.00% 06/16/09 $400,000 $400,000  1.04%
                 
Pipeline Data, Inc. -                
Convertible debenture (2)  8.00  06/29/10  500,000  519,231  1.36 
                 
        $
900,000
 $919,231  2.40%
    March 31, 2005 
  
Interest
Rate
 
Due
Date
 Cost 
Fair
Value
 
% of Net
Investments
 
Eligible Portfolio Investments -
Convertible Debentures and
Promissory Notes
                
                 
CaminoSoft Corp.
Promissory notes (4)
  7.00% 07/19/06 $250,000 $250,000  0.44%
                 
Digital Learning Management Corp. -
Convertible debenture (2)
  7.00  02/27/11  1,000,000  167,785  0.29 
                 
Hemobiotech, Inc. -                
Promissory note (2)  10.00  10/27/05  250,000  250,000  0.44 
                 
iLinc Communications, Inc. -
Convertible redeemable note (2)
  12.00  03/29/12  500,000  500,000  0.88 
                 
Integrated Security Systems, Inc. -                
Promissory notes (4)  8.00  09/30/05  525,000  525,000  0.92 
Promissory notes (4)  7.00  09/30/05  200,000  200,000  0.35 
                 
Simtek Corporation -
Convertible debenture
  7.50  06/28/09  1,000,000  1,794,872  3.15 
        $3,725,000 $3,687,657  6.47%
 

See accompanying notes
 
54



Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments, (continued)continued
(unaudited)

  September 30, 2006 
  Shares
 
Cost
 
Fair Value
 
% of Net Investments 
Eligible Portfolio Investments -         
Common Stock, Preferred Stock,         
and Miscellaneous Securities         
          
CaminoSoft Corp. -         
Common stock (2)  3,539,414 $5,275,000 $955,642  2.49 
              
eOriginal, Inc. -             
Series A, preferred stock (1)(2)(3)  10,680  4,692,207  332,575  0.87 
Series B, preferred stock (1)(2)(3)  25,646  620,329  798,616  2.08 
Series C, preferred stock (1)(2)(3)  51,249  1,059,734  1,595,894  4.17 
Series D, preferred stock (1)(2)(3)  16,057  500,000  500,015  1.30 
              
Gaming & Entertainment Group -             
Common stock (2)  612,500  550,625  67,375  0.18 
              
Gasco Energy, Inc. -             
Common stock  1,541,666  1,250,000  4,162,498  10.86 
              
Global Axcess Corporation -             
Common stock (2)  953,333  1,261,667  371,800  0.97 
              
Hemobiotech, Inc. -             
Common stock (2)  1,137,405  1,143,882  1,592,367  4.16 
              
Integrated Security Systems, Inc. -             
Common stock (2)  31,205,238  5,909,401  4,056,681  10.59 
Series D, preferred stock (2)  187,500  150,000  24,375  0.06 
              
Inyx, Inc. -             
Common stock  300,000  300,000  756,000  1.97 
              
PracticeXpert, Inc. -             
Common stock (2)  4,166,667  500,000  41,667  0.11 

    March 31, 2005 
  
Interest
Rate
 
Due
Date
 Cost 
Fair
Value
 
% of Net
Investments
 
Other Portfolio Investments -                
Convertible Debentures and Promissory Notes                
                 
Advanced Refractive Technologies (formerly VisiJet, Inc.)                
Convertible debenture (2)  8.00% 01/14/2015 $500,000 $557,143  0.98%
       $500,000 $557,143  0.98%
 

See accompanying notes
65



Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments, (continued)continued
(unaudited)

  September 30, 2006 
  Shares
 
Cost
 
Fair Value
 
% of Net Investments 
          
Eligible Portfolio Investments -         
Common Stock, Preferred Stock,         
and Miscellaneous Securities, continued         
          
Simtek Corp. -         
Common stock (2)  6,407,625  1,799,294  3,331,965  8.70 
              
Symbollon Pharmaceuticals, Inc. -             
Common stock (2)  250,000  250,000  312,500  0.82 
              
Miscellaneous Securities     -  562,943  1.47 
              
     $25,262,139 $19,462,913  50.80%
    March 31, 2005 
  Shares Cost 
Fair
Value
 
% of Net
Investments
 
Eligible Portfolio Investments -
Common Stock, Preferred Stock,
and Miscellaneous Securities
             
              
CaminoSoft Corp. -             
Common stock  1,750,000 $4,000,000 $735,000  1.29%
Common stock (2)  1,539,414  1,150,000  646,554  1.14 
Common stock (2)  250,000  125,000  105,000  0.18 
              
eOriginal, Inc. -             
Series A, preferred stock (1)(3)  10,680  4,692,207  387,671  0.68 
Series B, preferred stock (1)(3)  25,646  620,329  1,052,420  1.85 
Series C, preferred stock (1)(3)  51,249  1,059,734  1,391,463  2.45 
Series D, preferred stock (1)(3)  16,057  500,000  500,000  0.88 
              
Gaming & Entertainment Group, Inc.-
Common stock
  612,500  550,625  245,000  0.43 
              
Gasco Energy, Inc. - Common stock  1,541,667  1,250,000  4,671,251  8.21 
              
Global Axcess Corporation - Common stock (2)  4,766,667  1,261,667  1,525,333  2.68 
              
Hemobiotech, Inc. - Common stock (2)  294,120  250,000  250,000  0.44 
              
Integrated Security Systems, Inc. -             
Common stock (2)  27,074,179  5,568,058  9,205,221  16.18 
Series D, preferred stock (2)  187,500  150,000  76,500  0.13 
 

See accompanying notes
 
76

Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments, (continued)continued
(unaudited)

  September 30, 2006 
  Shares
 
Cost
 
Fair Value
 
% of Net Investments 
Other Portfolio Investments -         
Common Stock, Preferred Stock,         
and Miscellaneous Securities         
          
          
AdStar, Inc. -         
Common stock  269,231 $350,000 $223,462  0.58%
              
Advance Nanotech, Inc. -             
Common stock (2)  170,796  330,000  131,513  0.34 
              
Bovie Medical Corporation -             
Common stock (2)  500,000  907,845  3,520,000  9.19 
              
China Security & Surveillance Technology, Inc. -             
Common stock (2)  142,857  500,000  957,142  2.50 
              
Comtech Group, Inc. -             
Common stock (2)  240,000  840,000  3,597,600  9.39 
Common stock  60,000  346,018  899,400  2.35 
              
Hemobiotech, Inc. -             
Common stock  62,595  140,235  87,633  0.23 
              
i2 Telecom -             
Convertible Preferred (2)  625  618,750  44,531  0.11 
              
Information Intellect -             
Series A preferred stock (1)(2)(3)  666,666  999,999  999,999  2.61 
              
iLinc Communications, Inc. -             
Common stock  23,266  13,908  11,865  0.03 
              
Medical Action Industries, Inc. -             
Common stock  20,100  237,209  540,489  1.41 
 

    March 31, 2005 
  Shares Cost 
Fair
Value
 
% of Net
Investments
 
Eligible Portfolio Investments -
Common Stock, Preferred Stock,
and Miscellaneous Securities, continued
             
              
Inyx, Inc. - Common stock (2)  300,000  300,000  309,000  0.54 
              
Laserscope - Common stock  600,000  750,000  19,044,000  33.47 
              
Poore Brothers, Inc. - Common stock (2)  46,027  38,835  142,223  0.25 
              
PracticeXpert, Inc. - Common stock (2)  4,166,666  500,000  300,000  0.53 
              
Simtek Corp. -             
Common stock  1,000,000  195,000  560,000  0.98 
Common stock - private placement (2)  550,661  500,000  308,370  0.54 
              
Tarantella, Inc. - Common stock (2)  714,286  1,000,000  857,143  1.51 
              
ThermoView Industries, Inc. - Common stock  234,951  563,060  82,233  0.14 
              
Miscellaneous Securities       1,288,680  2.26 
     $25,024,515 $43,683,062  76.76%

See accompanying notes
87

 
Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments, (continued)continued
(unaudited)

  September 30, 2006 
  Shares
 
Cost
 
Fair Value
 
% of Net Investments 
Other Portfolio Investments -         
Common Stock, Preferred Stock,         
and Miscellaneous Securities, continued         
          
Precis, Inc. -         
Common stock (2)  800,000  1,998,894  1,560,000  4.07 
              
US Home Systems, Inc. -             
Common stock  110,000  535,587  1,040,600  2.72 
              
Vaso Active Pharmaceuticals, Inc. -             
Common stock  150,000  250,000  42,000  0.11 
              
      8,068,445  13,656,234  35.64%
              
     $37,280,584 $38,315,651  100.00%
              
Allocation of Investments -             
Restricted Shares, Unrestricted Shares,             
and Other Securities             
              
Restricted Securities (2)    $24,435,358 $24,211,662  63.19%
Unrestricted Securities    $3,422,957 $7,763,947  20.26%
Other Securities (5)    $9,422,269 $6,340,042  16.55%
 
(1)
Valued at fair value as determined by the Investment Adviser (Note 6).
(2)Restricted securities - securities that are not fully registered and freely tradable.
(3)Securities in a privately owned company.
(4)Securities that have no provision allowing conversion into a security for which there is a public market.
(5) Includes Miscellaneous Securities, securities of privately owned companies, securities with no conversion feature, and securities for which there is no market.
    March 31, 2005 
  Shares Cost 
Fair
Value
 
% of Net
Investments
 
Other Portfolio Investments -
Common Stock, Preferred Stock,
and Miscellaneous Securities
             
              
AdStar, Inc. - Common stock (2)  269,231 $350,000 $220,769  0.39%
              
Advance Nanotech, Inc. - Common stock (2)  165,000  330,000  1,196,250  2.10 
              
Bovie Medical Corporation - Common stock (2)  300,000  525,000  705,000  1.24 
              
Comtech Group, Inc. - Common stock (2)  240,000  840,000  1,440,000  2.53 
              
Cybex International - Common stock (2)  145,000  478,500  584,350  1.03 
              
iLinc Communications, Inc.- Common stock  48,266  27,033  17,859  0.03 
              
Gasco Energy, Inc. - Common stock  750,000  639,105  2,272,500  3.99 
              
i2 Telecom - Convertible Preferred (2)  625  618,750  581,250  1.02 
              
Medical Action Industries, Inc. - Common stock  20,100  237,209  379,890  0.67 
              
PhotoMedex, Inc. - Common stock  70,000  176,400  188,300  0.33 
              
Precis, Inc. - Common stock  200,700  1,372,417  340,387  0.60 
 

See accompanying notes
 
98


Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments, (continued)continued
(unaudited)
 
      December 31, 2005 
  Interest
 
Due
 
 
 
Fair
 
% of Net
 
 
 
Rate
 
Date
 
Cost
 
Value
 
Investments 
Eligible Portfolio Investments -           
Convertible Debentures and           
Promissory Notes           
            
CaminoSoft Corp. -           
Promissory note (4)  7.00  07/19/06 $250,000 $250,000  0.46%
                 
iLinc Communications, Inc. -                
Convertible promissory note (2)  12.00  03/29/12  500,000  500,000  0.93 
                 
Integrated Security Systems, Inc. -                
Promissory note (4)  8.00  09/30/06  525,000  525,000  0.97 
Promissory note (4)  7.00  09/30/06  200,000  200,000  0.37 
Promissory note (4)  8.00  09/30/06  175,000  175,000  0.33 
Convertible promissory note (2)  8.00  12/14/08  500,000  400,000  0.74 
                 
Simtek Corporation -                
Convertible debenture  7.50  06/28/09  1,000,000  1,000,000  1.85 
                 
        $3,150,000 $3,050,000  5.65%

    March 31, 2005 
  Shares Cost 
Fair
Value
 
% of Net
Investments
 
Other Portfolio Investments -
Common Stock, Preferred Stock,
and Miscellaneous Securities, continued
             
              
Stonepath Group, Inc. - Common stock  131,240  246,000  141,739  0.25 
              
Tarantella, Inc. - Common stock  202,762  186,541  243,314  0.43 
              
US Home Systems, Inc. - Common stock  110,000  535,587  572,000  1.01 
              
Vaso Active Pharmaceuticals, Inc. - Common stock  150,000  250,000  97,500  0.17 
              
      6,812,542  8,981,108  15.79%
     $36,062,057 $56,908,970  100.00%
              
Allocation of Investments -
Restricted Shares, Unrestricted Shares,
and Other Securities
             
              
Restricted Securities (2)    $16,235,810 $19,927,891  35.02%
Unrestricted Securities    $11,978,977 $31,385,845  55.15%
Other Securities (5)    $7,847,270 $5,595,234  9.83%
(1)Valued at fair value as determined by the Investment Adviser (Note 6).
(2)Restricted securities - securities that are not fully registered and freely tradable.
(3)Securities in a privately owned company.
(4)Securities that have no provision allowing conversion into a security for which there is a public market.
(5)Includes Miscellaneous Securities, securities of privately owned companies, securities with no conversion feature, and securities for which there is no market.

See accompanying notes
 
109



Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments (continued)
 
     December 31, 2005 
  
 
 
 
 
Fair
 
% of Net
 
 
 
Shares
 
Cost
 
Value
 
Investments 
Eligible Portfolio Investments -         
Common Stock, Preferred Stock,         
and Miscellaneous Securities         
          
CaminoSoft Corp. -         
Common stock  3,539,414 $5,275,000 $3,433,232  6.36 
              
eOriginal, Inc. -             
Series A, preferred stock (1)(2)(3)  10,680  4,692,207  332,575  0.62 
Series B, preferred stock (1)(2)(3)  25,646  620,329  798,616  1.48 
Series C, preferred stock (1)(2)(3)  51,249  1,059,734  1,595,894  2.96 
Series D, preferred stock (1)(2)(3)  16,057  500,000  500,015  0.93 
              
Gaming & Entertainment Group -             
Common stock (2)  612,500  550,625  79,625  0.15 
              
Gasco Energy, Inc. -             
Common stock  1,541,667  1,250,000  10,067,086  18.64 
              
Global Axcess Corporation -             
Common stock (2)  953,333  1,261,667  1,134,466  2.10 
              
Hemobiotech, Inc. -             
Common stock (2)  549,165  520,347  1,180,705  2.19 
              
Information Intellect -             
Series A preferred stock (1)(2)(3)  666,666  999,999  999,999  1.85 
              
Integrated Security Systems, Inc. -             
Common stock (2)  30,737,482  5,846,422  6,147,496  11.38 
Series D, preferred stock (2)  187,500  150,000  45,000  0.08 

    December 31, 2004 
  
Interest
Rate
 Due Date Cost 
Fair
Value
 
% of Net
Investments
 
Eligible Portfolio Investments -
Convertible Debentures and
Promissory Notes
                
                 
CaminoSoft Corp. -
Promissory note (4)
  7.00% 07/19/06 $250,000 $250,000  0.33%
                 
Digital Learning, Inc. -
Convertible debenture (2)
  7.00  02/27/11  1,000,000  1,342,282  1.76 
                 
Hemobiotech, Inc. -
Promissory note (2)
  10.00  10/27/05  250,000  250,000  0.33 
                 
iLinc Communications, Inc. -
Convertible promissory note (2)
  12.00  03/29/12  500,000  500,000  0.66 
                 
Integrated Security Systems, Inc. -                
Promissory note (4)  8.00  09/30/05  525,000  525,000  0.69 
Promissory note (4)  7.00  09/30/05  200,000  200,000  0.26 
                 
Simtek Corporation -
Convertible debenture (2)
  7.50  06/28/09  1,000,000  1,923,077  2.52 
        $3,725,000 $4,990,359  6.55%

See accompanying notes
 
10


Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments (continued)


    December 31, 2004 
  
Interest
Rate
 Due Date Cost 
Fair
Value
 
% of Net
Investments
 
Other Portfolio Investments -
Convertible Debentures and
Promissory Notes
                
                 
Interpool, Inc. -
Convertible debenture (2)
  9.25  12/27/22 $375,000 $375,000  0.49%
        $375,000 $375,000  0.49%

See accompanying notes
 
11


Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments (continued)

    December 31, 2005 
  
 
 
 
 
Fair
 
% of Net
 
 
 
Shares
 
Cost
 
Value
 
Investments 
Eligible Portfolio Investments -         
Common Stock, Preferred Stock,         
and Miscellaneous Securities, continued         
          
Inyx, Inc. -         
Common stock (2)  300,000  300,000  564,000  1.04 
              
Laserscope -             
Common stock  600,000  750,000  13,476,000  24.95 
              
PracticeXpert, Inc. -             
Common stock (2)  4,166,667  500,000  108,333  0.20 
              
Simtek Corp. -             
Common stock  1,550,661  695,000  449,692  0.83 
Common stock (2)  3,125,000  500,000  906,250  1.68 
              
Miscellaneous Securities    -  1,960,473  3.63 
              
     $25,471,330 $43,779,457  81.07%
 

    December 31, 2004 
  Shares Cost 
Fair
Value
 
% of Net
Investments
 
Eligible Portfolio Investments -
Common Stock, Preferred Stock,
and Miscellaneous Securities
             
              
CaminoSoft Corp. -             
Common stock  2,458,333 $4,875,000 $1,696,250  2.23%
Common stock (2)  1,081,081  400,000  745,946  0.98 
              
eOriginal, Inc. -             
Series A, preferred stock (1)(3)  10,680  4,692,207  332,575  0.44 
Series B, preferred stock (1)(3)  25,646  620,329  798,616  1.05 
Series C, preferred stock (1)(3)  51,249  1,059,734  1,595,894  2.09 
Series D, preferred stock (1)(3)  16,057  500,000  500,015  0.66 
              
Gaming & Entertainment Group -
Common stock (2)
  500,000  500,000  210,000  0.28 
              
Gasco Energy, Inc. -
Common stock (2)
  1,541,667  1,250,000  6,567,501  8.62 
              
Global Axcess Corporation -
Common stock (2)
  4,766,667  1,261,667  1,716,000  2.25 
              
Hemobiotech, Inc. -
Common stock (2)
  294,120  250,000  250,000  0.33 
              
Integrated Security Systems, Inc. -             
Common stock (2)  27,074,179  5,568,056  13,537,090  17.76 
Series D, preferred stock (2)  187,500  150,000  112,500  0.15 

See accompanying notes
12


Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments (continued)

    December 31, 2005 
  
 
 
 
 
Fair
 
% of Net
 
 
 
Shares
 
Cost
 
Value
 
Investments
 
Other Portfolio Investments -         
Common Stock, Preferred Stock,         
and Miscellaneous Securities         
          
AdStar, Inc. -         
Common stock (2)  269,231 $350,000 $600,385  1.11%
              
Advance Nanotech, Inc. -             
Common stock (2)  165,000  330,000  341,550  0.63 
              
Bovie Medical Corporation -             
Common stock (2)  500,000  904,545  1,490,000  2.76 
              
Comtech Group, Inc. -             
Common stock (2)  300,000  1,186,019  1,863,000  3.45 
              
i2 Telecom -             
Convertible Preferred (2)  625  618,750  50,781  0.10 
              
iLinc Communications, Inc. -             
Common stock  23,266  13,908  6,282  0.01 
              
Medical Action Industries, Inc. -             
Common stock  20,100  237,209  410,844  0.76 
              
Metasolv, Inc. -             
Common stock  100,000  210,838  290,000  0.54 
 

    December 31, 2004 
  Shares Cost Fair Value 
% of Net
Investments
 
Eligible Portfolio Investments -
Common Stock, Preferred Stock,
and Miscellaneous Securities, continued
             
              
Inyx, Inc. - Common stock (2)  300,000  300,000  417,000  0.55 
              
Laserscope - Common stock  600,000  750,000  21,546,000  28.27 
              
Poore Brothers, Inc. -
Common stock (2)
  1,507,791  1,544,294  5,262,191  6.91 
              
PracticeXpert, Inc. -
Common stock (2)
  4,166,666  500,000  562,500  0.74 
              
Simtek Corp. -             
Common stock (2)  550,661  500,000  330,397  0.43 
Common stock  1,000,000  195,000  600,000  0.79 
              
Tarantella, Inc. -
Common stock (2)
  714,286  1,000,000  1,200,000  1.57 
              
ThermoView Industries, Inc. -
Common stock
  234,951  563,060  122,175  0.16 
              
Miscellaneous Securities       1,051,436  1.38 
              
     $26,479,347 $59,154,086  77.63%

See accompanying notes
 
13


Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments (continued)

    December 31, 2005 
  
 
 
 
 
Fair
 
% of Net
 
 
 
Shares
 
Cost
 
Value
 
Investments 
Other Portfolio Investments -         
Common Stock, Preferred Stock,         
and Miscellaneous Securities, continued         
          
PhotoMedex, Inc. -         
Common stock  70,000  176,400  120,400  0.22 
              
Precis, Inc. -             
Common stock  800,000  1,998,894  1,232,000  2.28 
              
US Home Systems, Inc. -             
Common stock  110,000  535,587  701,800  1.30 
              
Vaso Active Pharmaceuticals, Inc. -             
Common stock  150,000  250,000  66,000  0.12 
              
      6,812,150  7,173,042  13.28%
              
     $35,433,480 $54,002,499  100.00%
              
Allocation of Investments -             
Restricted Shares, Unrestricted Shares,             
and Other Securities             
              
Restricted Securities (2)    $14,018,375 $15,411,591  28.54%
Unrestricted Securities    $12,392,836 $31,253,336  57.87%
Other Securities (5)    $9,022,269 $7,337,572  13.59%
 
(1)Valued at fair value as determined by the Investment Adviser (Note 6).
(2)Restricted securities - securities that are not fully registered and freely tradable.
    December 31, 2004 
  Shares Cost 
Fair
Value
 
% of Net
Investments
 
Other Portfolio Investments -
Common Stock, Preferred Stock,
and Miscellaneous Securities
             
              
AdStar, Inc. - Common stock (2)  269,231 $350,000 $293,462  0.39%
              
Bovie Medical Corporation -
Common stock (2)
  300,000  525,000  762,000  1.00 
              
Comtech Group, Inc. -
Common stock (2)
  480,000  840,000  1,435,200  1.88 
              
Cybex International -
Common stock (2)
  145,000  478,500  593,050  0.78 
              
Dave & Busters, Inc. -
Common stock
  100,000  653,259  2,020,000  2.65 
              
iLinc Communications, Inc. (formerly EDT Learning, Inc.) -
Common stock
  48,266  27,033  22,685  0.03 
              
Gasco Energy, Inc. -
Common stock
  750,000  639,105  3,195,000  4.19 
              
i2 Telecom -
Convertible preferred stock (2)
  500  500,000  500,000  0.66 
              
Intrusion, Inc. -
Convertible preferred stock (2)
  100,000  500,000  500,000  0.66 
              
Medical Action Industries, Inc. -
Common stock
  20,100  237,209  395,970  0.52 
              
PhotoMedex, Inc. -
Common stock
  70,000  176,400  189,000  0.25 
(3)Securities in a privately owned company.
(4)Securities that have no provision allowing conversion into a security for which there is a public market.
(5) Includes Miscellaneous Securities, securities of privately owned companies, securities with no conversion feature, and securities for which there is no market.
 

See accompanying notes
 
14


Renaissance Capital Growth & Income Fund III, Inc.
Schedules of Investments (continued)

    December 31, 2004 
  Shares Cost 
Fair
Value
 
% of Net
Investments
 
Other Portfolio Investments -
Common Stock, Preferred Stock,
and Miscellaneous Securities, continued
             
              
Precis, Inc. -
Common stock
  200,700  1,372,417  533,862  0.70 
              
Stonepath Group, Inc. - Common stock  131,240  246,000  157,488  0.21 
              
Tarantella, Inc. -
Common stock
  202,762  186,541  340,640  0.45 
              
US Home Systems, Inc. -
Common stock
  110,000  535,587  676,500  0.89 
              
Vaso Active Pharmaceuticals, Inc. -
Common stock
  150,000  250,000  69,000  0.09 
      7,517,051  11,683,857  15.33 
     $38,096,398 $76,203,302  100.00%
              
Allocation of Investments -
Restricted Shares, Unrestricted Shares,
and Other Securities
             
              
Restricted Securities (2)    $19,542,517 $39,385,196  51.69%
Unrestricted Securities    $10,706,611 $31,564,570  41.42%
Other Securities (5)    $7,847,270 $5,253,536  6.89%
(1)Valued at fair value as determined by the Investment Adviser (Note 6).
(2)Restricted securities - securities that are not fully registered and freely tradable.
(3)Securities in a privately owned company.
(4)Securities that have no provision allowing conversion into a security for which there is a public market.
(5)Includes Miscellaneous Securities, securities of privately owned companies, securities with no conversion feature, and securities for which there is no market.

See accompanying notes
15


Renaissance Capital Growth & Income Fund III, Inc.
Statements of Operations
(Unaudited)

  
Three Months Ended
September 30,
 
 
 
2006
 
2005 
      
Income:     
Interest income $125,296 $91,546 
Dividend income  236,814  45,661 
Write-off of interest receivable    (140,199)
Other income  (3,822) 5,386 
  
358,288
  2,394 
        
Expenses:       
General and administrative  63,538  166,376 
Interest expense    24,464 
Legal and professional fees  140,140  17,420 
Management fee to affiliate  237,776  278,937 
        
   441,454  487,197 
        
Net investment loss  (83,166) (484,803)
        
Realized and unrealized gain (loss)       
on investments:       
Net change in unrealized appreciation       
of investments  (2,379,862) 583,608 
Net realized gain on investments  874,823  1,304,189 
        
Net gain (loss) on investments  (1,505,039) 1,887,797 
        
Net income (loss) $(1,588,205)$1,402,994 
        
Net income (loss) per share $(0.36)$0.31 
        
Weighted average shares outstanding  4,463,967  4,451,495 

  Three Months Ended March 31, 
      
  2005 2004 
Income:       
Interest income $83,888 $79,963 
Dividend income  17,355  20,983 
Other income  50,625  28,282 
   151,868  129,228 
        
Expenses:       
General and administrative  73,662  103,364 
Interest expense  9,878  13,406 
Legal and professional fees  131,853  129,873 
Management fee to affiliate  273,293  410,131 
   488,686  656,774 
Net investment loss  (336,818) (527,546)
        
Realized and unrealized gain (loss) on investments:       
Net change in unrealized appreciation of investments  (17,259,989) 10,292,651 
Net realized gain on investments  4,093,083  14,163,079 
        
Net gain (loss) on investments  (13,166,906) 24,455,730 
        
Net income (loss) $(13,503,724)$23,928,184 
        
Net income (loss) per share $(3.06)$5.50 
        
Weighted average shares outstanding  4,412,831  4,351,718 
 
See accompanying notes
15

Renaissance Capital Growth & Income Fund III, Inc.
Statements of Operations
(Unaudited)

  Nine Months Ended September 30,
 
 
 
2006
 
2005 
      
Income:     
Interest income $244,630 $263,308 
Dividend income  347,037  106,705 
Write-off of interest receivable    (140,199)
Other income  19,954  72,957 
        
   611,621  302,771 
        
Expenses:       
General and administrative  235,777  267,562 
Interest expense  60,188  63,485 
Legal and professional fees  483,288  197,022 
Management fee to affiliate  723,239  826,961 
        
   1,502,492  1,355,030 
        
Net investment loss  (890,871) (1,052,259)
        
Realized and unrealized gain (loss)       
on investments:       
Net change in unrealized appreciation (depreciation)       
of investments  (17,533,952) (15,768,269)
Net realized gain on investments  19,686,060  5,493,584 
        
Net gain (loss) on investments  2,152,108  (10,274,685)
        
Net income (loss) $1,261,237 $(11,326,944)
        
Net income (loss) per share $0.28 $(2.54)
        
Weighted average shares outstanding  4,463,967  4,451,495 
See accompanying notes
16

 
Renaissance Capital Growth & Income Fund III, Inc.
Statements of Changes in Net Assets
(Unaudited)

  
Nine Months Ended
September 30,
 
 
 
2006
 
2005 
From operations:     
Net investment loss $(890,871)$(1,052,259)
Net realized gain on investments  19,686,060  5,493,584 
Net change in unrealized       
appreciation on investments  (17,533,952) (15,768,269)
        
Net income (loss)  1,261,237  (11,326,944)
        
From distributions to stockholders:       
Common stock dividends from realized       
capital gains  (1,339,190) (1,339,189)
        
From capital transactions:       
Sale of common stock    1,561,383 
        
Total decrease in net assets  (77,953) (11,104,750)
        
Net assets:       
Beginning of period  54,188,943  74,582,499 
        
End of period $54,110,990 $63,477,749 
 

  Three Months Ended March 31, 
  2005 2004 
From operations:       
Net investment loss $(336,818)$(527,546)
Net realized gain on investments  4,093,083  14,163,079 
Net change in unrealized appreciation on investments  (17,259,989) 10,292,651 
        
Net income (loss)  (13,503,724) 23,928,184 
        
From distributions to stockholders:       
Common stock dividends declared from realized capital gains  (446,396) (435,174)
        
From capital transactions:       
Sale of common stock  1,561,383   
        
Total increase (decrease) in net assets  (12,388,737) 23,493,010 
        
Net assets:       
Beginning of period  74,582,499  69,405,964 
        
End of period $62,193,762 $92,898,974 

See accompanying notes
 
17


Renaissance Capital Growth & Income Fund III, Inc.
Statements of Cash Flows
(Unaudited)

  
Nine Months Ended
September 30,
 
 
 
2006
 
2005 
      
Cash flows from operating activities:     
Net income (loss) $1,261,237 $(11,326,944)
Adjustments to reconcile net income (loss) to net cash       
provided by (used in) operation activities:       
Net decrease in unrealized appreciation       
on investments  17,533,952  15,768,269 
Net realized gain on investments  (19,686,060) (5,493,584)
Decreases in accounts receivable-broker    52,782 
Increase in interest and dividends       
receivable  (88,197) (1,194,291)
(Increase) decrease in prepaid and       
other assets  90,677  (49,616)
Increase in accounts payable  32,531  82,141 
Increase (decrease) in accounts payable-       
affiliate  (1,377,226) 520,065 
Decrease in due to broker  (2,075,975) (24,955,801)
Purchase of investments  (2,984,342) (2,828,590)
Proceeds from sale of investments  20,823,298  11,703,345 
        
Net cash provided by (used in) operating activities  13,529,895  (17,722,224)
        
Cash flows from financing activities:       
Cash dividends  (5,484,876) (13,393,447)
Sale of common stock    1,561,383 
        
Net cash used in financing activities  (5,484,876) (11,832,064)
        
Net increase (decrease) in cash       
and cash equivalents  8,045,019  (29,554,288)
        
Cash and cash equivalents at beginning       
of the period  8,396,052  37,278,871 
        
Cash and cash equivalents at end of period $16,441,071 $7,724,583 
        
Cash paid during the period Interest $60,188 $63,485 
  Three Months Ended March 31, 
  2005 2004 
Cash flows from operating activities:       
Net income (loss) $(13,503,724)$23,928,184 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:       
Net change in unrealized appreciation on investments  17,259,989  (10,292,651)
Net realized gain on investments  (4,093,083) (14,163,079)
(Increase) decrease in interest and dividends receivable  (10,480) 176,628 
Increase in prepaid and other assets  (59,420) (5,828)
Increase in accounts payable  45,419  63,846 
Decrease in accounts payable-affiliate  (134,964) (972,463)
Increase (decrease) in due to broker  (7,008,744) 3,915 
Purchase of investments  (995,104) (4,350,738)
Proceeds from sale of investments  7,122,539  15,814,708 
        
Net cash provided by (used in) operating activities  (1,377,572) 10,202,522 
        
Cash flows from financing activities:       
Cash dividends paid  (12,500,654) (4,134,134)
Sale of common stock  1,561,383   
        
Net cash used in financing activities  (10,939,271) (4,134,134)
        
Net increase (decrease) in cash and cash equivalents  (12,316,843) 6,068,388 
Cash and cash equivalents at beginning of the period  37,278,871  35,255,687 
        
Cash and cash equivalents at end of period $24,962,028 $41,324,075 
        
Cash paid during the period - interest $9,878 $13,406 

See accompanying notes
 
18


RENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC.
Notes to Unaudited Financial Statements
September 30, 2006March 31, 2005

Note 1 -
Organization and Business Purpose

Renaissance Capital Growth & Income Fund III, Inc. (the “Fund”), a Texas corporation, was formed on January 20, 1994. The Fund seeks to achieve current income and capital appreciation potential by investing primarily in unregistered equity investments and convertible issues of small and medium size companies which are in need of capital and which RENN Capital Group, Inc. (the “Investment Advisor”Adviser”), believes offer the opportunity for growth. The Fund is a non-diversified closed-end fund and has elected to be treated as a business development company under the Investment Company Act of 1940, as amended (“1940 Act”).

Note 2 -
Summary of Significant Accounting Policies

Basis of Presentation

We have prepared the accompanying unaudited interim financial statements pursuant to the rules and regulations of the Securities and Exchange Commission, which reflect all adjustments which, in the opinion of management, are necessary to present fairly the results for the interim periods. We have omitted certain information and disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States pursuant to those rules and regulations, although we believe that the disclosures we have made are adequate to make the information presented not misleading. You should read these unaudited interim financial statements in conjunction with our audited financial statements and notes included in our Annual Report on Form 10-K for the year ended December 31, 2005.2004.

The results of operations for the interim periods are not necessarily indicative of the results we expect for the full year.

Valuation of Investments

Portfolio investments are stated at quoted market or fair value as determined by the Investment Adviser (Note 6). The securities held by the Fund are primarily unregistered and their value does not necessarily represent the amounts that may be realized from their immediate sale or disposition.

Other

The Fund records security transactions on the trade date. Dividend income is recorded on the record date. Interest income is recorded as earned on the accrual basis.

Cash and Cash Equivalents

The Fund considers all highly liquid debt instruments with original maturities of three months or less to be cash equivalents.

19


RENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC.
Notes to Unaudited Financial Statements
March 31, 2005
Note 2 -
Summary of Significant Accounting Policies, continued

Federal Income Taxes

The Fund has elected the special income tax treatment available to “regulated investment companies” (“RIC”) under Subchapter M of the Internal Revenue Code (“IRC”) in order to be relieved of federal income tax on that part of its net investment income and realized capital gains that it pays out to its shareholders. The Fund’s policy is to comply with the requirements of the IRC that are applicable to regulated investment companies. Such requirements include, but are not limited to certain qualifying income tests, asset diversification tests and distribution of substantially all of the Fund’s taxable investment income to its shareholders. It is the intent of management to comply with all IRC requirements as they pertain to the RIC and to distribute all of the Fund’s taxable investment income and long-term capital gains within the defined period under the IRC to qualify as a RIC. Failure to qualify as a RIC would subject the Fund to federal income tax as if the Fund were an ordinary corporation, which could result in a substantial reduction in the Fund’s net assets as well as the amount of income available for distribution to shareholders.
 
19

RENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC.
Notes to Unaudited Financial Statements
September 30, 2006
Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts and disclosures in the financial statements. Actual results could differ from these estimates.

Note 3 -
Due to Broker

The Fund conducts business with various brokers for its investment activities. The clearing and depository operations for the investment activities are performed pursuant to agreements with these brokers. Due to broker represents a margin loan payable to one of these brokers, which is secured by investments in securities maintained with the lending broker as collateral for the margin loan. Cash and cash equivalents related to the margin loan payable are held by the lending broker as additional collateral for the margin loan. The Fund is subject to credit risk to the extent the brokers are unable to deliver cash balances or securities, or clear security transactions on the Fund’s behalf. The Investment Adviser actively monitors the Fund’s exposure to these brokers and believes the likelihood of loss under those circumstances is remote.

Note 4 -
Management and Incentive Fees

The Investment Adviser for the Fund is registered as an investment adviser under the Investment Advisers Act of 1940.1940 (the “Advisers Act”). Pursuant to an Investment Advisory Agreement (the “Agreement”), the Investment Adviser performs certain services, including certain management, investment advisory and administrative services necessary for the operation of the Fund. In addition, under the Agreement, the Investment Adviser is reimbursed by the Fund for certain directly allocable administrative expenses. A summary of fees and reimbursements paid by the Fund under the Agreement, isthe prospectus and the original offering document are as follows:
20


RENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC.
Notes to Unaudited Financial Statements
March 31, 2005
Note 4 -
Management and Incentive Fees, continued

·     The Investment Adviser receives a management fee equal to a quarterly rate of 0.4375% of the Fund’s net assets, as determined at the end of such quarter with each such payment to be due as of the last day of the calendar quarter. The Fund incurred $723,239$273,293 and $826,961$410,131 for management fees during the nine monthsquarters ended September 30, 2006March 31, 2005 and 2005,2004, respectively.

·     The Investment Adviser receives an incentive fee in an amount equal to 20% of the Fund’s cumulative realized capital gains in excess of cumulative realized capital losses of the Fund after allowance for any unrealized capital depreciation on the portfolio investments of the Fund at the end of the period being calculated less cumulative incentive fees previously accrued. Unrealized capital depreciation equals net unrealized capital loss on each class of security without netting net unrealized capital gains on other classes of securities. Because the incentive fee is calculated, accrued, and paid on an annual basis as of each year end and no probability or estimate of the ultimate fee can be ascertained, (see note 8), no incentive fee was recorded during the nine monthsquarters ended September 30, 2006 or 2005.

20


RENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC.
Notes to Unaudited Financial Statements
September 30, 2006

Note 4 -
ManagementMarch 31, 2005 and Incentive Fees, continued
2004.

·     The Investment Adviser was reimbursed by the Fund for administrative expenses paid by the Investment Adviser on behalf of the Fund. Such reimbursements were $49,977$86,139 and $95,672$158,281 during the nine monthsquarters ended September 30, 2006March 31, 2005 and 2005, respectively, and are included in general and administrative expenses in the accompanying statements of operations.2004, respectively.

As of September 30, 2006March 31, 2005 and December 31, 2005,2004, the Fund had an accountsaccount payable to the Investment Advisor of $673,763$3,562,507 and $2,050,989,$3,697,461, respectively, for the amount due for the fees and expense reimbursements above.

As explained in Note 9, during 2005 the Investment Adviser resolved a dispute with the staff of the Securities and Exchange Commission involving the appropriate interpretation of section 205(b)(3) of the Advisers Act. As part of the settlement, the Investment Adviser agreed to pay $2,851,362 as a reduction of incentive fees for the period from inception through December 31, 2003. The Fund reported a receivable of $3,775,872 as of March 31, 2005 and December 31, 2004 to reflect the settlement which included interest income of $924,510, all of which was recognized in periods prior to January 1, 2004.

Note 5 -
Eligible Portfolio Companies and Investments

Eligible Portfolio Companies

The Fund invests primarily in convertible securities and equity investments of companies that qualify as Eligible Portfolio Companies as defined in Section 2(a)(46) of the 1940 Act or in securities that otherwise qualify for investment as permitted in Section 55(a)(1) through (5). of the 1940 Act. Under the provisions of the 1940 Act, at least 70% of the Fund’s assets, as defined under the 1940 Act, must be invested in Eligible Portfolio Companies. In the event the Fund has less than 70% of its assets invested in Eligible Portfolio Investments, then it will be prohibited from making non-eligible investments until such time as the percentage of eligible investments again exceeds the 70% threshold. The Fund was in compliance with these provisions at September 30, 2006.March 31, 2005.
21


RENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC.
Notes to Unaudited Financial Statements
March 31, 2005
Note 5 -
Eligible Portfolio Companies and Investments, continued

Investments

Investments are carried in the statements of assets and liabilities at fair value, as determined in good faith by the Investment Adviser. The convertible debt securities held by the Fund generally have maturities between five and seven years and are convertible into the common stock of the issuer at a set conversion price at the discretion of the Fund. The common stock underlying these securities is generally unregistered and thinly to moderately traded, but is not otherwise restricted. Generally, the Fund maynegotiates registration rights at the time of purchase and the portfolio companies are required to register the shares within a designated period and sell such securities at any time with the Fund payingcost of registration is borne by the costs of registration.portfolio company. Interest on convertible securities is generally payable monthly. The convertible debt securities generally contain embedded call options giving the issuer the right to call the underlying issue. In these instances, the Fund has the right of redemption or conversion. The embedded call option will generally not vest until certain conditions are achieved by the issuer. Such conditions may require that minimum thresholds be met relating to underlying market prices, liquidity, or other factors.

Note 6 -
Valuation of InvestmentInvestments

On a quarterly basis, the Investment Adviser prepares a valuation of the assets of the Fund, subject to the approval of the Board of Directors of the Fund. The valuation principles are described below.

·     The common stock of companies listed on an exchange, Nasdaq or in the over-the-counter market is valued at the closing price on the date of valuation.

·     The unlisted preferred stock of companies with common stock listed on an exchange, Nasdaq or in the over-the -counterover-the-counter market is valued at the closing price of the common stock into which the preferred stock is convertible on the date of valuation. If the preferred stock is redeemable, the preferred stock is valued at the greater of cost or market.
21

RENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC.
Notes to Unaudited Financial Statements
September 30, 2006

Note 6
Valuation of Investment, continued

·     The unlisted in-the-money options or warrants of companies with the underlying common stock listed on an exchange, Nasdaq or in the over-the-counter market are valued at the positive difference between the closing price of the underlying common stock and the strike price of the warrant or option. An out-of-the money warrant or option has no intrinsic value; thus, we assign no value to it.

·     Debt securities are valued at the greater of (i) cost or (ii) the market value of the underlying common stock into which the debt instrument is convertible. In cases where the debt instrument is in default or the company is in bankruptcy, the value will be (i) the value of the underlying common stock, (ii) the value of the collateral, if secured, or (iii) zero, if the common stock has no value and there is no collateral.
22


RENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC.
Notes to Unaudited Financial Statements
March 31, 2005
Note 6 -
Valuation of Investments, continued

·     If there is no independent and objective pricing authority (i.e. a public market) for investments in privately held entities, the latest sale of equity securities to independent third parties by the entity governs the value of that enterprise. This valuation method causes the Fund’s initial investment in the private entity to be valued at cost. Thereafter, new issuances or offers of equity or equity-linked securities by the portfolio company to new investors will be used to determine enterprise value as they will provide the most objective and independent basis for determining the worth of the issuer. Where a private entity does not have an independent value established over an extended period of time, then the Investment Adviser will determine fair value on the basis of appraisal procedures established in good faith and approved by the Fund’s Board of Directors.

As of September 30, 2006,March 31, 2005 and December 31, 2005,2004, the net unrealized appreciation associated with investments held by the Fund was $1,035,067$20,846,913 and $18,569,019,$38,106,903, respectively. As of September 30, 2006For the periods ended March 31, 2005 and December 31, 2005,2004, the Fund had gross unrealized gains of $15,072,033$32,786,443 and $28,008,507,$47,453,782, respectively, and gross unrealized losses of $(14,036,966)$11,939,529 and $(9,439,488),$9,346,879, respectively.

Note 7 -
Restricted Securities

As indicated on the schedules of investments as of September 30, 2006March 31, 2005 and December 31, 2005,2004, the Fund holds investments in shares of common stock, the sale of which is restricted. These securities have been valued by the Investment Adviser after considering certain pertinent factors relevant to the individual securities (See Note 6).

Note 8 -
Distribution to Shareholders

During the three months ended March 31, 2004, the Fund declared dividends of $435,172. During the three months ended March 31, 2005, the Fund declared dividends of $446,397.
Note 9 -
Settlement with the Investment Advisor

During 2004, the staff of the Securities and Exchange Commission (“SEC”) informed the Fund’s counsel of potential significant regulatory issues in connection with the Staff’s review of a registration statement for a proposed rights offering. On December 1, 2005, the Investment Adviser consented, without admitting or denying the findings, to the entry of an order by the SEC instituting public administrative and cease and desist proceedings and imposing remedial sanctions (the “Order”).
23


RENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC.
Notes to Unaudited Financial Statements
March 31, 2005
Note 9 -
Settlement with the Investment Advisor, continued

In summary, the dispute concerned the definition of the wording of the incentive fee calculation in the Advisers Act. Under Section 205(b)(3) of the Advisers Act, a performance fee may be earned. The Investment Adviser, for many years, believed the word “capital” referred to the Fund’s shareholders equity as a whole. In 2004, the SEC informed the Investment Adviser that capital depreciation in the formula referred only to unrealized capital losses on marketable securities in the portfolio and therefore the calculations in previous years were incorrect. In the Order, the SEC states that in calculating a performance-based fee under Section 205(b)(3), an Investment Adviser must account for its client’s assets on a security-by-security basis and may not take into consideration unrealized capital appreciation on any individual security or the portfolio as a whole. Section 205(b)(3) does not require that fees earned in one period be subject to repayment based upon performance in a subsequent period. If the performance fee is calculated on a cumulative basis and is based on the period since inception, the unrealized capital depreciation may be calculated for each calculation period by subtracting each security’s valuation at the end of the applicable calculation period from the original cost, as adjusted, of purchasing that security. In practice, the Investment Adviser also took into account unrealized capital appreciation, which offset unrealized capital depreciation, to calculate its performance-based fee. Thus, beginning in fiscal year 1996, the first period in which the Fund realized capital gains, the Investment Adviser’s formula for calculating that fee was not consistent with the agreed formula permitted under Section 205(b)(3).

As part of the settlement of the SEC proceedings, the Investment Adviser agreed to pay $2,851,362 for adjustments in the incentive fee from the inception through December 31, 2003, plus prejudgment interest of $924,509 and a penalty of $100,000 to the Fund.

The Investment Adviser satisfied this obligation in full as of December 8, 2005.

The effect of the SEC settlement, was reflected retroactively. As such the effect of the adjustments in incentive fees were reported in prior years as though the agreed methodology had been in place since inception. Interest received by the fund upon settlement was allocated to the years in which it was earned. The $100,000 penalty received upon settlement was reflected in the year settlement was reached (2005).

Note 10 -
Commitments and Contingencies

As disclosed in Note 4, the Fund is obligated to pay to the Investment AdvisorAdviser an incentive fee equal to 20% of the Fund’sfunds cumulative realized capital gains in excess of cumulative capital losses of the Fund after allowance for any capital depreciation on the portfolio investments of the Fund. As incentive fees on capital gains are not due to the Investment AdvisorAdviser until the capital gains are realized, any obligations for incentive fees based on unrealized capital gains are not reflected in the accompanying financial statements as there is no assurance that the unrealized gains as of the end of any period will ultimately become realized. Had an incentive fee been accrued as a liability based on all unrealized capital gains, net assets of the Fund would have been reduced by $5,509,555$9,447,335 as of December 31, 2005.2004.
 
2224


RENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC.
Notes to Unaudited Financial Statements
September 30, 2006March 31, 2005

Note 911 -
Financial Highlights - unaudited

Selected per share data and ratios for each share of common stock outstanding throughout the ninethree months ended September 30, 2006March 31, 2005 and 20052004 are as follows:

  2005   2004   
      
Net asset value, beginning of period $17.14 $15.95 
        
Effect of share change  (.43) - 
Net investment loss  (.08) (.12)
Net realized and unrealized gain (loss) on investments 
   (2.95  5.62 
        
Total return from investment operations  (3.46) 5.50 
        
Shares issued  .35  .00 
        
Distributions  (.10) (.10)
        
Net asset value, end of period $13.93 $21.35 
        
Per share market value, end of period $11.40 $17.24 
        
Portfolio turnover rate (quarterly)  1.50% 6.58%
Quarterly return (a)  (11.97)% 28.75%
        
Ratio to average net assets (quarterly) (b):       
Net investment income (loss)  (0.49)% (0.65)%
Expenses  .72% .81%
  2006  
 
2005   
Net asset value, beginning of period $12.14 $16.71 
        
Net investment loss  (0.20) (0.24)
Net realized and unrealized gain on investments  0.48  (2.30)
        
Total return from investment operations  0.28  (2.54)
        
Capital share transactions    0.35 
Distributions  (0.30 (0.30
        
Net asset value, end of period  12.12  14.22 
        
Per share market value, end of period $11.61 $11.25 
        
Portfolio turnover rate  6.40% 4.54%
Quarterly return (a)  5.55% (13.13%)
Ratio to average net assets (b):       
Net investment income (loss)  (1.63%) (1.60%)
Expenses  2.75% 2.06%

(a)      NineThree month return (not annualized) was calculated by comparing the common stock price on the first day of the period to the common stock price on the last day of the period, in accordance with American Institute of Certified Public AccountAccountants guidelines.

(b)      Average net assets have been computed based on quarterly valuations.

2325

 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsOperations..

Material Changes in Portfolio Investments

The following material portfolio transactions occurred during the quarter ended September 30, 2006:March 31, 2005:

Advance Nanotech, Inc. (OTCBB:AVNA) During the first quarter of 2005, the Fund bought 165,000 shares of common stock and warrants to purchase 82,500 shares of common stock for $330,000.

Advanced Refractive Technologies (formerly VisiJet, Inc.) (formerly known as Visijet) (OTCBB:ARFR): In During the first quarter of 2006,2005, the Fund recordedbought a $125,000 receivable relatedconvertible debenture and warrants to the salepurchase 500,000 shares of debt securities of Advanced Refractive Technologies. The Fund received a payment of $62,500 in the second quarter of 2006. The Fund wrote-off the remaining $62,500 accrual in the third quarter of 2006.common stock at $0.40 per share for $500,000.

Integrated Security Systems,CNE Group, Inc. (OTCBB:IZZI): In(AMEX:CNE) During the thirdfirst quarter of 2006,2005, the Fund received 134,074allowed warrants to purchase 62,500 shares of common stock with a value of $17,644 at the time of issuance, as payment in kind for interest on promissory notes held by the Fund.to expire.

Laserscope,Comtech Group, Inc. (Nasdaq:LSCP):COGO) During the thirdfirst quarter of 2006,2005, the company declared a 1 for 2 stock split. After the stock split, the Fund tendered options to purchase 34,923held 240,000 shares of the company’s common stock, realizing proceeds of $843,192 representing a gain of $843,192.stock.

Metasolv,Dave & Buster’s, Inc. (OTCBB:MSLV):(NYSE:DAB) During the thirdfirst quarter of 2006,2005, the Fund sold 100,000 shares of common stock realizing proceeds of $304,970$1,894,526, representing a gain of $94,132.$1,241,267.

Simtek CorporationGaming & Entertainment Group, Inc. (Nasdaq:GMEI) During the first quarter of 2005, the company incurred a penalty for failing to comply with the terms of its offering. Thus, the Fund received 112,500 shares of common stock with an implied cost basis of $50,625.

i2 Telecom International, Inc. (OTCBB:SRAM): DuringITUI) In the first quarter ended September 30, 2006,of 2005, the Fund bought 125 shares of Series D preferred stock and warrants to purchase 78,125 shares of common stock for $118,750.

Interpool, Inc. (AMEX:IPX) In the first quarter of 2005, the Fund sold a $375,000 9.25% debenture realizing proceeds of $408,750, representing a gain of $33,750.

Intrusion, Inc. (OTCBB:INTZ) In the first quarter of 2005, the Fund converted a $100,000 debenture into 454,545$500,000 of preferred stock to 159,033 shares of common stock. The Fund also purchased 1,265,823immediately sold the common stock realizing proceeds of $740,361, representing a gain of $240,361.

Poore Brothers, Inc. (Nasdaq:SNAK) In the quarter ended March 31, 2005, the Fund sold 1,461,764 shares of common stock and warrants to purchase 189,874 sharesrealizing proceeds of common stock at $0.54 per share for $500,000.$4,078,903, representing a gain of $2,573,444.

26

Results of Operations for the Three MonthsQuarter Ended September 30, 2006March 31, 2005

For the quarter ended September 30, 2006,March 31, 2005, the Fund had a net investment loss of $83,166$336,818 compared to a net investment loss of $484,803$527,546 for the thirdfirst quarter of 2005.2004. This change was due in large part to an increasea decrease in investment incomeexpenses from $2,394$656,774 for the thirdfirst quarter of 20052004 to $358,288$488,686 for the comparable period of 2006.2005. This increasedecrease in investment incomeexpenses was primarily attributable to higher interest and dividend incomea decrease in management fee for the thirdfirst quarter of 2006. Interest2005. Other income increased $22,343 primarily from $91,546 for the three months ended September 30, 2005 to $125,296 for the same periodreceipt of 2006, primarily as a result of the recovery of interest incomelate S-3 filing fee from iLinc Communications,Gaming & Entertainment Group, Inc. that had been previously written off. Dividend income for the three-month period ended September 30, 2006, was $236,814 versus $45,661 for the same period in 2005 as a result of higher balances in 2006 of short-term treasury investments that earn dividends. There were no interest receivable write-offs during the three months ended September 30, 2006; however, during the comparable period of 2005, the Fund wrote off $140,199 of interest that was determined to be uncollectable.
24


Expenses decreased from $487,197 for the quarter ended September 30, 2005 to $441,454 for the third quarter of 2006. March 31, 2005.

General and administrative expenses decreased for the third quarter of 2006 to $63,538 from $166,376 for the third quarter of 2005, primarily due to decreased travel, subscriptions, bank charges, and insurance expenses, offset by higher investor relations and director fee expenses. Interest expense decreased from $24,464 for the thirdfirst quarter of 2005 to $0$73,662 from $103,364 for the first quarter of 2004 as a result of no annual fee being paid for NASDAQ listing for 2005. Management fees decreased from $410,131 for the first quarter of 2004 to $273,293 for the comparable period of 2006 as a result of repayment of margin balances in June 2006. Legal and professional fees increased from $17,420 for the third quarter of 2005 to $140,140 in the same period of 2006 as a result of higher audit and consulting fees for the third quarter of 2006. These increased fees were a result of the Fund completing the 2003, 2004 and 2005 audits during 2006 and starting the reviews of 2006 quarterly financial information. Management fees decreased from $278,937 for the third quarter of 2005 to $237,776 for the third quarter of 2006 as a result of lower market values for portfolio investments at September 30, 2006.March 31, 2005.

Net change in unrealized appreciation was an increase of $10,292,651 for the quarter ended September 30, 2005 was $583,608. For the quarter ended September 30, 2006March 31, 2004. The net change in unrealized appreciation was a decrease of $2,379,862 as a result$17,259,989 for the quarter ended March 31, 2005. The variance was due to the fluctuation of fluctuations in market values of securities at each quarter end and the realization of gains or losses upon the disposition of investments.

RealizedNet realized gains decreased from $1,304,189$14,163,179 for the quarter ended September 30, 2005March 31, 2004 to $874,823$4,093,083 for the same period in 2006. The difference isof 2005. During the result of fewerquarter ended March 31, 2004 the Fund realized gains recorded fromprimarily on the sale of investments during the quarter ended September 30, 2006.

Results of Operations for the Nine Months Ended September 30, 2006

Laserscope common stock. For the nine months ended September 30, 2006, the Fund experienced net investment loss in the amount of $890,871, compared to a net investment loss in the amount of $1,052,259 for the same period in 2005. This change was due in part to an increase in investment income from $302,771 for the nine months ended September 30, 2005 to $611,621 for the comparable period of 2006. This increase in investment income was partially attributable to higher dividend income being earned in 2006. Dividend income for the nine-month period ended September 30, 2006 was $347,037 versus $106,705 for the same period in 2005 as a result of higher balances in 2006 of short-term treasury investments that earn dividends. There were no interest receivable write-offs during the nine months ended September 30, 2006; however, during the comparable period of 2005 the Fund wrote off $140,199 of interest that was determined to be uncollectable.
25

Expenses increased from $1,355,030 for the nine months ended September 30, 2005 to $1,502,492 for the same period in 2006. General and administrative expenses decreased from $267,562 in the nine months ended September 30, 2005, to $235,777 for the same period in 2006,gains were realized primarily due to lower subscription, and insurance expenses, offset by higher investor relations, printing, taxes, and director’s fee expenses in 2006. Legal and professional fees increased from $197,022 for the nine months ended September 30, 2005 to $483,288 for the nine months ended September 30, 2006 as a result of higher audit and consulting fees for the nine months ended September 30, 2006. These increased fees were a result of the Fund completing the 2003, 2004 and 2005 audits during 2006 and starting the reviews of 2006 quarterly financial information. Management fees decreased from $826,961 for the nine months ended September 30, 2005, to $723,239 for the same period in 2006, due to lower market values for portfolio investments at September 30, 2006.

Net change in unrealized appreciation on investments was a decrease of $15,768,269 for the nine months ended September 30, 2005, and $17,533,952 for the nine months ended September 30, 2006. The difference between the net change for the two periods is the result of fluctuations in market values of securities at each quarter end and the realization of gains or losses upon disposition of investments.

Realized gains increased from $5,493,584 for the nine months ended September 30, 2005 to $19,686,060 for the same period in 2006, as a result of gains earned from the sale of investments (primarily Laserscope) during the nine months ended September 30, 2006.common stock from Poore Brothers, Inc. and Dave & Buster’s, Inc.

Liquidity and Capital Resources

For the ninethree months ended September 30, 2006,March 31, 2005, net assets decreased from $54,188,943$74,582,499 at December 31, 20052004 to $54,110,990$62,193,762 at September 30, 2006.March 31, 2005. This decrease is primarily attributable to dividends declared of $1,339,190a decrease in net unrealized appreciation due to fluctuations in market values. This decrease was partially offset by increased distributable net incomecapital gains from the sale of 1,261,237 forinvestments and additional paid in capital from the nine monthsissuance of shares per the dividend reinvestment plan in the quarter ended September 30, 2006.March 31, 2005.

At the end of the thirdfirst quarter of 2006,2005, the Fund had cash and cash equivalents of $16,441,071$24,962,028 versus cash and cash equivalents of $8,396,052$37,278,871 at December 31, 2005.2004. This increase isdecrease was primarily attributable to the receiptJanuary 2005 payment of proceeds of $18,464,321 from the sale of Laserscope common stock.dividend payable at December 31, 2004. The Fund’s interest and dividends receivable increased from $48,226$95,689 at December 31, 2004 to $106,169 at March 31, 2005 primarily due to $136,423 at September 30, 2006 due primarily to more dividends being recorded on higher short-term treasuryinterest accrued from an additional investment balances. In addition,in an Advanced Refractive Technologies convertible debenture during the nine monthsquarter ended September 30, 2006, the Fund purchased an additional promissory note and convertible debenture from Integrated Security Systems, Inc. and a convertible debeture from Pipeline Data, Inc.March 31, 2005.
During the nine months ended September 30, 2006, the Fund paid the accounts payable due to broker margin balance with part of the proceeds from the sale of Laserscope. Also, the dividend payable of $4,145,686 to shareholders of record as of December 30, 2005 was paid on January 12, 2006.

2627


Accounts payable increased from $86,782$51,477 at December 31, 20052004 to $119,313$96,896 at September 30, 2006March 31, 2005 primarily due to the accrual of audit and consulting fees. Finally, accountslegal fees during the quarter ended March 31, 2005. Accounts payable to affiliate decreased from $2,050,989$3,697,461 at December 31, 2004 to $3,562,507 at March 31, 2005 to $673,763 at September 30, 2006, reflecting the payments of accrued management and incentive feesdue to the Fund’s investment adviser.payment of expenses and management fees accrued at December 31, 2004 offset by the accrual of management fee for the first quarter of 2005.

Due to broker decreased from $27,001,414 at December 31, 2004 to $19,992,670 at March 31, 2005. Due to broker represents a margin loan. The margin loan payable at December 31, 2004 was paid in January 2005. During March 2005 the Fund acquired a new margin loan.

During the nine monthsquarter ended September 30, 2006March 31, 2005 the Fund paid $5,484,876$12,500,654 of dividends to shareholders of which $4,145,686$12,054,258 was capital gains dividend payable at December 31, 20052004 and $1,339,190$446,396 was payment of dividends declared during the nine monthsquarter ended September 30, 2006.

During the nine months ended September 30, 2006, the Fund invested $2,984,342 in new and follow-on investments compared to $2,828,590 for the same period inMarch 31, 2005. During the nine months ended September 30, 2006, the Fund received $20,823,298 in proceeds from the sale of the securities of various portfolio companies, including $18,464,321 from the sale of Laserscope common stock and a recovery of $1,091,200 of the Fund’s original $3,135,000 investment in Dexterity Surgical, Inc. which had previously been written-off. During the same nine month period of 2005, the Fund received $11,964,359 in proceeds from the sale of portfolio company securities.

The majority of the Fund’s investments in portfolio companies are individually negotiated, non-registered for public trading, and are subject to legal and contractual investment restrictions. Accordingly, the Fund’s portfolio investments are generally considered non-liquid. This lack of liquidity primarily affects the Fund’s ability to make new investments and distributions to shareholders.

Pending investment in portfolio investments, funds are invested in temporary cash accounts and in government securities. Government securities used as cash equivalents will typically consist of U. S. Treasury securities or other U. S. Government and Agency obligations having slightly higher yields and maturity dates of three months or less. These investments qualify for investment as permitted in Section 55(a)(1) through (5) of the 1940 Act.

Contractual Obligations

The Fund has a contract for the purchase of services under which it will have future commitments: the investment advisory agreement, pursuant to which RENN Capital Group, Inc. has agreed to serve as the Fund’s investment adviser. Such agreement has contractual obligations with fees which are based on values of the portfolio investments which the Fund owns. For further information regarding the Fund’s obligations under the investment advisory agreement see Note 4 of the Financial Statements.
27


Because the Fund does not enter into other long-term debt obligations, capital lease obligations, operating lease obligations, or purchase obligations, a table of contractual obligations has not been presented.

28


Item 3. Quantitative and Qualitative Disclosure About Market Risk

The Fund is subject to financial market risks, including changes in market interest rates as well as changes in marketable equity security prices. The Fund does not use derivative financial instruments to mitigate any of these risks. The return on the Fund’s investments is generally not affected by foreign currency fluctuations.

A majority of the Fund’s net assets consistsconsist of common stocksstock, and warrants and options to purchase common stock, in publicly traded companies. These investments are directly exposed to equity price risk, in that a percentage change in these equity prices would result in a similar percentage change in the fair value of these securities.

A lesser percentage of the Fund’s net assets consist of fixed rate convertible debentures and other debt instruments as well as convertible preferred securities. Since these instruments are generally priced at a fixed rate, changes in market interest rates do not directly impact interest income, although they could impact the Fund’s yield on future investments in debt instruments. In addition, changes in market interest rates are not typically a significant factor in the Fund’s determination of fair value of its debt instruments, as it is generally assumed they will be held to maturity, and their fair values are determined on the basis of the terms of the particular instrument and the financial condition of the issuer.

A small percentage of the Fund’s net assets consist of equity investments in private companies. The Fund would anticipateanticipates no impact on these investments from modest changes in public market equity prices. However, should significant changes in market prices occur, there could be a longer-term effect on valuations of private companies which could affect the carrying value and the amount and timing of proceeds realized on these investments.

Item 4. Controls and Procedures.

The Fund has in place systems relating to disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Our principal executive officer and principal financial officer evaluated the effectiveness of these disclosure controls and procedures as of the end of our quarter ended September 30, 2006March 31, 2005 in connection with the preparation of this report. They concluded that the controls and procedures were effective and adequate at that time. There were no significant changes in the Fund’s internal control over financial reporting during the thirdfirst quarter of fiscal 20062005 that have materially affected, or are reasonably likely to materially affect, the Fund’s internal control over financial reporting.

2829


PART II
 
Item 1.
Legal Proceedings

None

Item 1A.
Risk Factors

You should carefully consider the risks described below and all other information contained in this quarterly report on Form 10-Q, including our financial statements and the related notes thereto before making a decision to purchase our common stock. The risks and uncertainties described below are not the only ones facing us. Additional risks and uncertainties not presently known to us, or not presently deemed material by us, may also impair our operations and performance. If any of the following risks actually occur, our business, financial condition or results of operations could be materially adversely affected. If that happens, the trading price of our common stock could decline, and you may lose all or part of your investment.

Failure to Meet Listing Standards. It is uncertain whether our common stock will meet the requirements for listing on Nasdaq, or any other stock exchange or quotation service.

In July 2004, due to our inability to complete our audit and file our Form 10-K for the year ended December 31, 2003 in a timely manner, the Fund’s common stock was delisted from Nasdaq. As we become current with the delinquent filings, we will attempt to relist with Nasdaq or a national stock exchange, but there is no certainty that we will be able to do so.

Our Growth is Dependent on Investing in Quality Transactions. Sustaining growth depends on our ability to identify, evaluate, finance, and invest in companies that meet our investment criteria. Accomplishing such results on a cost-effective basis is a function of our marketing capabilities and skillful management of the investment process. Failure to achieve future growth could have a material adverse effect on our business, financial condition, and results of operations.

Failure to Invest Capital Effectively May Decrease Our Stock Price. If we fail to invest our capital effectively, our return on equity may be decreased, which could reduce the price of the shares of our common stock.

Highly Competitive Market for Investments. We compete with a number of private equity funds, other investment entities and individuals for investment opportunities. Some of these competitors are substantially larger and have greater financial resources, and some are subject to different and frequently less stringent regulation. As a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time and there can be no assurance that we will be able to identify and make investments that satisfy our objectives.

2930


Lack of Publicly Available Information on Certain Portfolio Companies. Some of the securities in our portfolio are issued by privately held companies. There is generally little or no publicly available information about such companies, and we must rely on the diligence of our management to obtain the information necessary for our decision to invest. There can be no assurance that such diligence efforts will uncover all material information necessary to make fully informed investment decisions.

Dependence on Key Management. Selecting, structuring and closing our investments depends upon the diligence and skill of our management, which is responsible for identifying, evaluating, negotiating, monitoring and disposing of our investments. Our management's capabilities will significantly impact our results of operations. If we lose any member of our management team and he/she cannot be promptly replaced with an equally capable team member, our results of operations could be significantly impacted.

Failure to Deploy Capital may Lower Returns. Our failure to successfully deploy sufficient capital may reduce our return on equity.

Results May Fluctuate. Our operating results may fluctuate materially due to a number of factors including, among others, variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our portfolio companies’ markets, the ability to find and close suitable investments, and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods.

Uncertain Value of Certain Restricted Securities. Our net asset value is based on the values assigned to the various investments in our portfolio, determined in good faith by our board of directors. Because of the inherent uncertainty of the valuation of portfolio securities which do not have readily ascertainable market values, our fair value determinations may differ materially from the values which would be applicable to unrestricted securities having a public market.

Illiquid Securities May Adversely Affect Our Business. Our portfolio contains securities which are subject to restrictions on sale because they were acquired from issuers in "private placement" transactions or because we are deemed to be an affiliate of the issuer. Unless an exemption from the registration requirements of the Securities Act of 1933 is available, we will not be able to sell these securities publicly without the expense and time required to register the securities under applicable federal and state securities laws. In addition, contractual or practical limitations may restrict our ability to liquidate our securities in portfolio companies, because we may own a relatively large percentage of the issuer's outstanding securities. Sales may also be limited by unfavorable market conditions. The illiquidity of our investments may preclude or delay the disposition of such securities, which may make it difficult for us to obtain cash equal to the value at which we record our investments.

3031

 
Regulated Industry. Publicly traded investment funds are highly regulated. Changes in securities laws or regulations governing our operations or our failure to comply with those laws or regulations may adversely affect our business.

Failure to Qualify for Favorable Tax Treatment. We may not qualify for conduit tax treatment as a Regulated Investment Company ("RIC") if we are unable to comply with the requirements of Subchapter M of the Internal Revenue Code. If we fail to satisfy such requirements and cease to qualify for conduit tax treatment, we will be subject to federal taxes on our net investment income. The loss of this pass-through tax treatment could have a material adverse effect on the total return, if any, obtainable from an investment in our common stock.

Highly Leveraged Portfolio Companies. Some of our portfolio companies could incur substantial indebtedness in relation to their overall capital base. Such indebtedness often has a term that will require the balance of the loan to be refinanced when it matures. If portfolio companies cannot generate adequate cash flow to meet the principal and interest payments on their indebtedness, the value of our investments could be reduced or eliminated through foreclosure on the portfolio company's assets or by the portfolio company's reorganization or bankruptcy.

Our Common Stock Often Trades at a Discount. Our common stock often trades at a discount from net asset value. Our common stock is traded over-the-counter in the pink sheets. Stockholders desiring liquidity may sell their shares at current market value, which has often been below net asset value. Shares of closed-end investment companies frequently trade at discounts from net asset value, which is a risk separate and distinct from the risk that a fund's performance will cause its net asset value to decrease.

Nature of Investment in Our Common Stock. Our stock is intended for investors seeking long-term capital appreciation. Our investments in portfolio securities generally require some time to reach maturity, and such investments generally are illiquid. An investment in our shares should not be considered a complete investment program. Each prospective purchaser should take into account his or her investment objectives as well as his or her other investments when considering the purchase of our shares.

Our Stock Price May Fluctuate Significantly. The market price of our common stock may fluctuate significantly. The market price and marketability of shares of our common stock may from time to time be significantly affected by numerous factors, including our investment results, market conditions, and other influences and events over which we have no control and that may not be directly related to us.

3132


Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3.
Defaults Upon Senior Securities

None

Item 4.
Submission of Matters to a Vote of Security Holders
 
None

Item 5.
Other Information

None

Item 6.
Exhibits

 31.1Certification of the principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 31.2Certification of the principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 32.1Certification of the principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 32.2Certification of the principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

3233


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Fundregistrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

RENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC.


 /s/ Russell ClevelandRENAISSANCE CAPITAL GROWTH & INCOME FUND III, INC. December 19, 2006
Russell Cleveland, President and
Chief Executive Officer
(Principal Executive Officer)
  
   
 
/s/ Russell ClevelandNovember 14, 2006

Russell Cleveland, President
and Chief Executive Officer
(Principal Executive Officer)
/s//s/ Barbe Butschek  November 14,December 19, 2006

Barbe Butschek, Chief Financial Officer
(Principal Financial Officer)
  

3334